<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The primary objective of this study is to confirm the efficacy and safety of combination therapy with antibacterial and <z:chebi fb="0" ids="35718">antifungal drugs</z:chebi> for patients with <z:e sem="disease" ids="C0947743,C0018939" disease_type="Disease or Syndrome" abbrv="">hematological disorders</z:e> complicated with <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> of unknown causative organisms </plain></SENT>
<SENT sid="1" pm="."><plain>The subjects consisted of 55 patients with <z:e sem="disease" ids="C0947743,C0018939" disease_type="Disease or Syndrome" abbrv="">hematological disorders</z:e>, 28 males and 27 females, ranging from 1 to 78 years of age, with an average age of 34 years </plain></SENT>
<SENT sid="2" pm="."><plain>The breakdown of the patients by disease was: 41 <z:hpo ids='HP_0001909'>leukemias</z:hpo>, 10 malignant <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, 3 <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> and an <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients were treated with <z:chebi fb="0" ids="9321">sulbactam</z:chebi>/cefoperazone (SBT/<z:chebi fb="0" ids="3647">CPZ</z:chebi>) and <z:chebi fb="0" ids="47779">aminoglycoside</z:chebi> (AG) plus <z:chebi fb="2" ids="46081">fluconazole</z:chebi> (FLCZ) as an empiric therapy </plain></SENT>
<SENT sid="4" pm="."><plain>Overall efficacy rate was 54.5% for <z:hpo ids='HP_0000001'>all</z:hpo> the patients: 57.7% for patients with suspected <z:hpo ids='HP_0100806'>sepsis</z:hpo> and 0% for those with <z:hpo ids='HP_0002090'>pneumonia</z:hpo> from which unknown organisms were detected </plain></SENT>
<SENT sid="5" pm="."><plain>The efficacy rate was 59.4% for patient who had been previously treated with other antibiotics and 47.8% for those who had not previously been treated </plain></SENT>
<SENT sid="6" pm="."><plain>The above results suggested that this combination therapy might be effective for severe <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> of unknown causative organisms associated with <z:e sem="disease" ids="C0947743,C0018939" disease_type="Disease or Syndrome" abbrv="">hematological disorders</z:e> </plain></SENT>
</text></document>